{"_self":{"principle":"Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.","widget":"article_topology","feature":"topology","name":"Article topology","what":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","contains":"claims, sources, anecdotes, question_graph slice","slug":"tesamorelin-sciatica","urls":{"read":"https://miscsubjects.com/api/articles/tesamorelin-sciatica/topology"},"how_to_use":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","write":null,"imessage":null,"router_tag":null,"proof_chain":[{"step":1,"claim":"Articles are voxel graphs of tiered claims, not prose blobs.","verify":"https://miscsubjects.com/api/articles/constitution"},{"step":2,"claim":"Claims link to hash-chained sources via source_ids.","verify":"https://miscsubjects.com/api/articles/tesamorelin-sciatica/sources"},{"step":3,"claim":"Ask reads topology; ingest/claim append to ledger.","verify":"https://miscsubjects.com/api/protocol"},{"step":4,"claim":"Models queue growth: populate → collaborate → repair → reflex.","verify":"https://miscsubjects.com/api/protocol/grow"},{"step":5,"claim":"Graph proves its own shape (reflex) and $/claim (yield).","verify":"https://miscsubjects.com/graph.html?layer=reflex"},{"step":6,"claim":"Full feature index + _explain on every API response.","verify":"https://miscsubjects.com/api/articles/system-map"}],"related_features":[{"id":"ask","name":"Ask protocol","what":"Answer only from topology; creates question_node with gaps and ingest_hint.","urls":{"read":"https://miscsubjects.com/api/articles/tesamorelin-sciatica/prompts","write":"https://miscsubjects.com/api/protocol/ask"}},{"id":"graph_topology","name":"Cross-article graph","what":"Merged claims/sources across condition+stack slugs for one question.","urls":{"read":"https://miscsubjects.com/api/articles/tesamorelin-sciatica/graph-topology?question=..."}},{"id":"question_graph","name":"Question graph","what":"Ask nodes (questions + gaps) and evidence_ingest nodes (pasted model output).","urls":{"read":"https://miscsubjects.com/api/articles/tesamorelin-sciatica/question-graph","write":"https://miscsubjects.com/api/protocol/ask"}},{"id":"voxels","name":"Voxel graph","what":"Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance.","urls":{"read":"https://miscsubjects.com/api/articles/tesamorelin-sciatica/voxels","write":"https://miscsubjects.com/api/protocol/claim"}}],"system_map":"https://miscsubjects.com/api/articles/system-map","system_map_markdown":"https://miscsubjects.com/api/articles/system-map?format=markdown","not_medical_advice":true},"_explain":{"feature":"topology","name":"Article topology","what":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","why":"Every feature is auditable collective intelligence","how":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","model":null,"verifies":null,"urls":{"read":"https://miscsubjects.com/api/articles/tesamorelin-sciatica/topology"},"imessage":null,"router":null,"related":[{"id":"ask","what":"Answer only from topology; creates question_node with gaps and ingest_hint."},{"id":"graph_topology","what":"Merged claims/sources across condition+stack slugs for one question."},{"id":"question_graph","what":"Ask nodes (questions + gaps) and evidence_ingest nodes (pasted model output)."},{"id":"voxels","what":"Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance."}],"not_medical_advice":true},"slug":"tesamorelin-sciatica","title":"Tesamorelin for Sciatica: Evidence on Repair Layers vs Symptom Suppression","register":"source_ledger","tags":["peptide","matrix"],"updated_at":"2026-07-17T02:42:26.023Z","body_excerpt":"## What's breaking down if you have Sciatica\n\nSciatica involves nerve pain along the sciatic nerve, often from disc herniation or spinal stenosis compressing a nerve root. The nerve signals damage or compression. Suppressing pain signals does not address the compression or the underlying tissue breakdown. Repair pathways must outpace ongoing degeneration for symptoms to resolve long-term. Mechanical factors like excess visceral fat can add compressive load on the lumbar spine.\n\n## Why Tesamorelin might help you\n\n1. You have Sciatica — breakdown is outpacing repair.\n2. Therefore for you: If visceral fat or growth hormone axis issues contribute to mechanical load or poor tissue turnover, Tesamorelin is discussed because it targets the GH axis and visceral fat reduction — not because it masks pain.\n3. This article centers Tesamorelin; see other sections for BPC-157, TB-500, ARA-290 — different layers, same condition.\n\n## Why BPC-157 might help you\n\n1. You have Sciatica — breakdown is outpacing repair.\n2. What keeps failing: Poor blood supply at injury sites, weak collagen organization, slow tissue turnover.\n3. What BPC-157 is studied to do: Studied for growing new blood vessels (angiogenesis) so repair material reaches damaged tissue.\n4. Therefore for you: If that layer is part of your problem, BPC-157 is discussed because it targets repair (structure / tissue) — not because it masks pain.\n\n## Why TB-500 might help you\n\n1. You have Sciatica — breakdown is outpacing repair.\n2. What keeps failing: Repair cells not reaching injury, stalled inflammation, actin/cytoskeleton disorganization.\n3. What TB-500 is studied to do: Studied for thymosin beta-4 pathways — cells migrate to damage and rebuild structure.\n4. Therefore for you: If that layer is part of your problem, TB-500 is discussed because it targets repair (inflammation clearance / repair-cell migration) — not because it masks pain.\n\n## Why ARA-290 might help you\n\n1. You have Sciatica — breakdown is outpacing repair.\n2. What keeps failing: Nerve compression, small-fiber loss, neuropathic pain signaling without tissue repair.\n3. What ARA-290 is studied to do: Studied for nerve repair and small-fiber regeneration in neuropathy models.\n4. Therefore for you: If that layer is part of your problem, ARA-290 is discussed because it targets repair (nerve / innervation) — not because it masks pain.\n\n## How these fit together\n\nEach compound above targets a different degeneration layer. Together they are a stack — not five copies of the same mechanism.\n- Tesamorelin → GH axis / visceral fat\n- BPC-157 → structure / tissue\n- TB-500 → inflammation clearance / repair-cell migration\n- ARA-290 → nerve / innervation\n\nPrimary focus of this slug: Tesamorelin. Others are in scope because the same condition breaks down on multiple layers.\n\n## What the evidence actually shows\n\nHuman data on Tesamorelin for sciatica is absent. One ongoing phase 2 trial tests it for peripheral nerve injury recovery (human, recruiting). Phase 3 HIV trials showed visceral fat reduction but listed back pain among adverse events (human). BPC-157 rat studies on transected sciatic nerve showed faster axonal regeneration, improved motor action potentials, and better sciatic functional index versus controls (preclinical). TB-500 (thymosin beta-4) mouse studies in diabetic neuropathy improved sciatic nerve conduction velocity and function (preclinical). ARA-290 human trials in sarcoidosis small fiber neuropathy patients improved neuropathic symptom scores and corneal nerve fiber density versus placebo (human). No human trials link any of these directly to sciatica resolution.\n\n## What scientists say\n\nResearchers note Tesamorelin's selectivity for the GHRH receptor and visceral fat effects in HIV populations. Animal nerve injury models for BPC-157 and TB-500 demonstrate structural and functional recovery endpoints. ARA-290 studies highlight innate repair receptor activation leading to measurable small fiber regrowth in human neuro","ranking":"safety-first (interaction_risk/limitations), then quote-gated effective_weight","claims":[{"id":"c1","text":"One ongoing phase 2 trial tests tesamorelin for peripheral nerve injury recovery.","tier":"human","weight":0.8,"section":"What the evidence actually shows","slot":null,"interaction_risk":false,"status":"active","source_ids":["s1"],"source_status":"sourced","why_material":"Direct human trial link to nerve injury relevant to sciatica compression.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.8,"quote_gated":false},{"id":"c2","text":"Rat studies show BPC-157 improved axonal regeneration and functional recovery after sciatic nerve transection.","tier":"preclinical","weight":0.5,"section":"What the evidence actually shows","slot":null,"interaction_risk":false,"status":"active","source_ids":["s2"],"source_status":"sourced","why_material":"Specific preclinical evidence on sciatic nerve repair layer.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.5,"quote_gated":false},{"id":"c3","text":"ARA-290 improved neuropathic symptoms and corneal nerve fiber density in human small fiber neuropathy trials.","tier":"human","weight":0.8,"section":"What the evidence actually shows","slot":null,"interaction_risk":false,"status":"active","source_ids":["s3"],"source_status":"sourced","why_material":"Human data on nerve repair relevant to neuropathic component of sciatica.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.22,"quote_gated":true},{"id":"c4","text":"TB-500 improved sciatic nerve function in diabetic neuropathy animal models.","tier":"preclinical","weight":0.5,"section":"What the evidence actually shows","slot":null,"interaction_risk":false,"status":"active","source_ids":["s4"],"source_status":"sourced","why_material":"Preclinical support for inflammation clearance and nerve repair layer.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.22,"quote_gated":true}],"sources":[{"id":"s1","type":"clinical_trial","url":"https://www.withpower.com/trial/phase-3-peripheral-nerve-injuries-5-2018-b26fd","title":"Tesamorelin for Peripheral Nerve Injury","quote":"This trial tests whether tesamorelin, a growth hormone-releasing factor, can aid recovery from peripheral nerve injuries, such as an ulnar nerve cut at the wrist.","summary":"Phase 2 trial recruiting for tesamorelin in peripheral nerve injury recovery.","claim_ids":["c1"],"link_status":"ok","quote_status":"verified","hash":"7aa30a3d6623a375b4e5c9d036c84b453ef8eefef6b4e964698569c5810c694f"},{"id":"s2","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/19903499/","title":"Peptide therapy with pentadecapeptide BPC 157 in traumatic nerve injury","quote":"BPC 157 markedly improved rat sciatic nerve healing.","summary":"Rat study on BPC-157 improving transected sciatic nerve healing and function.","claim_ids":["c2"],"link_status":"ok","quote_status":"verified","hash":"aded0bf9f72123266dd83fb8e041014f17c1bbd45e648f93e6ab8df257d0e4f7"},{"id":"s3","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/24555851/","title":"ARA 290 for treatment of small fiber neuropathy in sarcoidosis","quote":"ARA 290 treatment was consistently associated with a significant improvement of neuropathic pain symptoms in sarcoidosis patients.","summary":"Human trial showing ARA-290 benefits in small fiber neuropathy symptoms.","claim_ids":["c3"],"link_status":"ok","quote_status":"unverified","hash":"6a32108c64dccd620df939142c97cb26d724076621c3bcbb0e482b09d1296eb2"},{"id":"s4","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3533234/","title":"Thymosin β4 Promotes the Recovery of Peripheral Neuropathy","quote":"The present study indicates that Tβ4 ameliorates diabetic peripheral neuropathy, evidenced by reduction of sciatic nerve conduction velocity deficits.","summary":"Animal study on thymosin beta-4 improving sciatic nerve parameters in neuropathy model.","claim_ids":["c4"],"link_status":"ok","quote_status":"unverified","hash":"ea941231b21b23d057a44364b5a03d81a3af52cea3c9a126bbcf97e4caefcf54"}],"anecdotal_sources":[],"scientific_sources":[{"id":"s1","type":"clinical_trial","url":"https://www.withpower.com/trial/phase-3-peripheral-nerve-injuries-5-2018-b26fd","title":"Tesamorelin for Peripheral Nerve Injury","quote":"This trial tests whether tesamorelin, a growth hormone-releasing factor, can aid recovery from peripheral nerve injuries, such as an ulnar nerve cut at the wrist.","summary":"Phase 2 trial recruiting for tesamorelin in peripheral nerve injury recovery.","claim_ids":["c1"],"link_status":"ok","quote_status":"verified","hash":"7aa30a3d6623a375b4e5c9d036c84b453ef8eefef6b4e964698569c5810c694f"},{"id":"s2","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/19903499/","title":"Peptide therapy with pentadecapeptide BPC 157 in traumatic nerve injury","quote":"BPC 157 markedly improved rat sciatic nerve healing.","summary":"Rat study on BPC-157 improving transected sciatic nerve healing and function.","claim_ids":["c2"],"link_status":"ok","quote_status":"verified","hash":"aded0bf9f72123266dd83fb8e041014f17c1bbd45e648f93e6ab8df257d0e4f7"},{"id":"s3","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/24555851/","title":"ARA 290 for treatment of small fiber neuropathy in sarcoidosis","quote":"ARA 290 treatment was consistently associated with a significant improvement of neuropathic pain symptoms in sarcoidosis patients.","summary":"Human trial showing ARA-290 benefits in small fiber neuropathy symptoms.","claim_ids":["c3"],"link_status":"ok","quote_status":"unverified","hash":"6a32108c64dccd620df939142c97cb26d724076621c3bcbb0e482b09d1296eb2"},{"id":"s4","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3533234/","title":"Thymosin β4 Promotes the Recovery of Peripheral Neuropathy","quote":"The present study indicates that Tβ4 ameliorates diabetic peripheral neuropathy, evidenced by reduction of sciatic nerve conduction velocity deficits.","summary":"Animal study on thymosin beta-4 improving sciatic nerve parameters in neuropathy model.","claim_ids":["c4"],"link_status":"ok","quote_status":"unverified","hash":"ea941231b21b23d057a44364b5a03d81a3af52cea3c9a126bbcf97e4caefcf54"}],"user_reports":[],"related_articles":[],"question_graph":{"slug":"tesamorelin-sciatica","questions":[],"evidence":[],"edges":[],"counts":{"questions":0,"evidence":0,"edges":0}},"honesty":{"active_claims":4,"retracted_claims":0,"cut_claims":0,"challenges":0,"scrub_events":0,"note":"Retracted/cut claims stay on ledger but are excluded from ask unless ?include_inactive=1"},"counts":{"claims":4,"claims_total":4,"sources":4,"anecdotal":0,"scientific":4,"user_reports":0,"questions":0,"evidence_ingests":0}}